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Membrane structureTo characterize the structure and dynamics of cholesterol in membranes, ﬂuorescent analogs of the native mol-
ecule have widely been employed. The cholesterol content in membranes is in general manipulated by using
water-soluble cyclodextrins. Since the interactions between cyclodextrins and ﬂuorescent-labeled cholesterol
have not been investigated in detail so far, we have compared the cyclodextrin-mediated membrane extraction
of three different ﬂuorescent cholesterol analogs (one bearing a NBD and two bearing BODIPYmoieties). Extrac-
tion of these analogs was followed by measuring the Förster resonance energy transfer between a rhodamine
moiety linked to phosphatidylethanolamine and the labeled cholesterol. The extraction kinetics revealed that
the analogs are differently extracted from membranes. We examined the orientation of the analogs within the
membrane and their inﬂuence on lipid condensation using NMR and EPR spectroscopies. Our data indicate
that the extraction of ﬂuorescent sterols from membranes is determined by several parameters, including
their impact on lipid order, their hydrophobicity, their intermolecular interactions with surrounding lipids,
their orientation within the bilayer, and their afﬁnity with the exogenous acceptor.
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Cholesterol is one of the most intensively investigated biological
molecules [1]. This high interest is justiﬁed by the essential physio-
logical roles cholesterol plays in eukaryotic cells. Examples are the
role of cholesterol for the formation of lateral membrane domains
[2,3], maintenance ofmembrane permeability, andmembrane trafﬁcking
(see [4]). To improve our understanding about the physiological roles of
cholesterol on themolecular level, ﬂuorescent analogs have been studied
in ﬂuorescence microscopy and spectroscopy (see [5,6] and refer-
ences cited therein). Since water-soluble cyclodextrins (CDs), espe-
cially methyl-β-cyclodextrin (MβCD), are able to form complexes with
endogenous cholesterol [7], it is possible to efﬁciently manipulate the
level of cholesterol and its analogs in model and biological membranes.
However, the ability of the ﬂuorescent analogs to reﬂect the properties
of endogenous cholesterol [8] and the inﬂuence of the ﬂuorophore on
CD-cholesterol interaction must be critically considered. For the latter,
various studies have shown that CDs are also able to complex ﬂuores-
cence groups [9–12]. Therefore, we have characterized the interaction
of ﬂuorescent (NBD- and BODIPY-) labeled sterols (structures see Fig. 1)
with CDs by investigating the ability of CDs to extract the analogs from
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BODIPY-labeled analog (BODIPY-cholesterol, referred to here as BCh-1)
mimics the properties of native cholesterol ratherwell, in that it, similarly
to cholesterol, partitions preferentially into liquid-ordered lipid domains
[13]. The other BODIPY-labeled analog (BCh-2), which has an artiﬁcial
ester linkage within the side chain and was synthesized as a negative
control, was shown (i) in monolayer studies not to mix ideally with
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and not to
result in condensation of the mixed monolayer area and (ii) in lipid ves-
icles not to partition into liquid-ordered lipid domains [13,14]. The NBD-
labeled cholesterol (NBDCh) has been shown not to speciﬁcally mimic
the molecular behavior of native cholesterol [8]. We established an
assay to measure the kinetics of CD-mediated cholesterol extraction
from membranes based on Förster resonance energy transfer (FRET) be-
tween the ﬂuorescent cholesterol analogs as the donor and rhodamine-
labeled phosphatidylethanolamine (Rh-PE) as the acceptor. We found
that the cholesterol analogs are extracted differently from lipid mem-
branes. In order to search for reasons of these differences, we measured
the orientation of cholesterol analogs within the lipid membrane and
their lipid condensation effect in comparison with that of endogenous
cholesterol.
2. Materials and methods
2.1. Materials
POPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-
palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (POPC-d31),
1-palmitoyl-2-stearoyl-(5/10/16-doxyl)-sn-glycero-3-phosphocholine
(5-/10-/16-doxyl-PC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho
(Tempo)choline (Tempo-PC), 25-{N-[(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)-methyl]amino}-27-norcholesterol (NBDCh), N-(lissamine rhodamine
B sulfonyl)-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (Rh-PE),
and cholesterol were purchased from Avanti Polar Lipids (Alabaster,
AL). The BODIPY-labeled analogs of cholesterol, 23-(4,4-diﬂuoro-
1,3,5,7-tetramethyl-4-bora-3a,4a-diazas-indacen-8-yl)-24-norchol-
5-en-3β-ol (BCh-1) and 22-[4-(4,4-diﬂuoro-1,3,5,7-tetramethyl-4-
bora-3a,4a-diaza-s-indacen-8-yl)-butyroxy]24-bisnorchol-5-en-3β-ol
(BCh-2) were synthesized using the method described in [14]. BCh-1 is
also referred to as BODIPY-cholesterol and TopFluorCholesterol. αCD,
βCD, (2-hydroxy)propyl-βCD (HPβCD), 2,6-di-O-methyl-β-CD (MβCD),
and γCD were provided from Cyclolab (Budapest, Hungary). All
other chemicals were from Sigma-Aldrich (Taufkirchen, Germany).
The HEPES buffered solution (HBS) contained 145 mM NaCl and
10 mM HEPES (pH 7.4).
2.2. Preparation of LUVs and multilamellar vesicles (MLVs)
LUVs were prepared by the extrusion method [15]. The desired
amount of lipids (DOPC and ﬂuorescent lipids at 0.5 mol% if not stat-
ed otherwise) was dissolved in chloroform and dried in a rotating
round-bottom ﬂask under vacuum until a lipid ﬁlm was formed. To
evaporate the remaining solvent completely, the ﬁlm was dried
under high vacuum for at least 15 min. Lipids were hydrated with a
small volume of ethanol and HBS, giving a ﬁnal concentration of
1 mM (ﬁnal ethanol concentration, b1% (v/v)). To prepare LUVs,Fig. 1. Structures of the ﬂuorescent chothe MLV suspension was subjected to ﬁve freeze–thaw cycles followed
by extrusion of the lipid suspension at room temperature 10 times at
40 °C through two 0.1 μm polycarbonate ﬁlters (mini-extruder from
Avanti Polar Lipids; ﬁlters from Costar, Nucleopore, Tübingen, Germany).
MLVs were used in the NMR experiments. After the lipids were
mixed in chloroform, the solvent was evaporated and the samples
were dissolved in cyclohexane and lyophilized to provide a ﬂuffy pow-
der that was hydrated with 40 wt.% deuterium-depleted water for 2H
NMR or with D2O for 1H NMR measurements. For equilibration, the
samples were subjected to ten freeze–thaw cycles and centrifuged ten
times. The specimens were transferred into 5-mm glass vials for 2H
NMR experiments and into 4-mm high-resolution MAS rotors for 1H
MAS NMR.
2.3. Measurement of extraction of cholesterol analogs
The assay for measuring the extraction of cholesterol analogs from
membranes was based on the approach described by John et al. [16] in
which FRET between dehydroergosterol (DHE) and dansyl-labeled phos-
phatidylethanolamine (PE) was used. Here, we used FRET between the
NBD or BODIPY moiety linked to cholesterol and the rhodamine (Rh)
moiety linked to PE. LUVs were prepared containing DOPC, Rh-PE, and
the respective cholesterol analog (BCh-1, BCh-2, or NBDCh); excitation
of the BODIPY or NBD moiety results in Rh ﬂuorescence when the
ﬂuorophores are proximal to each other. A speciﬁc extraction of labeled
cholesterols to an extravesicular acceptor, e.g. CD, results in a decrease
of FRET. Therefore, the FRET signal of LUVs upon the addition of CDs is
used to monitor the release of cholesterol from the bilayers.
50 μl of LUV solution (containing 1 mM of lipids, 0.5 mol% Rh-PE,
and the respective cholesterol analog) was mixed with 1.45 ml of HBS
in a ﬂuorescence cuvette. The time-dependent ﬂuorescence intensity
was recorded (excitation 470 nm, emission 590 nm, slit widths 4 nm)
at 37 °C. After 30 s, CDs were added at the concentrations shown in
the respective ﬁgures. After 300 s, Triton X-100 (ﬁnal concentration,
0.5% (w/v)) was added to diminish the FRET completely. Curves were
normalized by setting the ﬂuorescence intensities before addition of
CD to one and the intensities after addition of Triton X-100 to zero. Fluo-
rescence kinetics were recorded using an Aminco Bowman Series 2
spectroﬂuorometer (Urbana, IL).
Quantitative data of the kinetics were obtained by ﬁtting the curves
to a model applied for the extraction of short-chain phospholipids from
membranes [17]. The model considers the ﬂip-ﬂop of cholesterol ana-
logs between the inner and outer leaﬂets of the vesicle membranes
and the extraction of cholesterol analogs from the outer leaﬂet by an ac-
ceptor as well as its back insertion. In the case of very rapid extraction
kinetics, the model was over-parameterized. Therefore, in these cases,
the curves were ﬁtted to a single-exponential equation, giving the rate
constant and the plateau of extraction (see Results).
2.4. Fluorescence quenching experiments
Themembrane orientation and distribution of the ﬂuorescent choles-
terol analogs were determined by measuring the extent of ﬂuorescence
quenching in the presence of different spin-labeled PCs. LUVs were pre-
pared containing 5 mol% of Tempo-PC, 5-Doxyl-PC, 10-Doxyl-PC, or 16-
Doxyl-PC, respectively, 90 mol% POPC, and 5 mol% of the cholesterollesterol analogs used in this study.
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rameter, the spin density of each labeled lipid was determined by dou-
ble integration of the ERR signal. Additionally, an inorganic phosphorus
analysis was performed to determine the exact concentration of lipids
in the preparation. Furthermore, an aliquot of the samples was lyophi-
lized and subsequently dissolved in chloroform. Fluorescencemeasure-
ments were performed again to determine the concentration of the
ﬂuorescent molecules in the samples.
Fluorescence spectra were recorded using an ISA Jobin Yvon Spex
Fluoromax2 spectrometer. The excitation wavelength was 495 nm for
BCh-1, 480 nm for BCh-2, and 490 nm for NBDCh. The quenching efﬁ-
ciency is the difference between the ﬂuorescence intensity of the
cholesterol analogs in the absence and in the presence of quencher
molecules. The calculated quenching efﬁciencies were corrected by
the measured spin density, the phosphate concentration, and the rela-
tive concentration of the ﬂuorescent molecules in the sample.
2.5. NMR measurements
MLVs containing 80 mol% POPC for 1HMASNMR or POPC-d31 for 2H
NMR and 20 mol% of the ﬂuorescent cholesterol analog were pre-
pared. 1H MAS NMR spectra were recorded on a DRX600 NMR spec-
trometer (Bruker BioSpin GmbH, Karlsruhe, Germany). A 4-mm high
resolution MAS probe was used. The MAS frequency was set to
8 kHz. The typical length of a π/2 pulse was 9.8 μs. The two dimen-
sional 1H MAS NOESY experiments were recorded at various mixing
times between 1 ms and 500 ms.
2H NMR spectra were acquired on a Bruker Avance I 750 MHz NMR
spectrometer operating at a resonance frequency of 46.1 MHz for 2H.
The relaxation delay was set to 1 s. Typical π/2 pulses were around
3.4 μs. A quadrupolar echo pulse sequence was used, and the delay be-
tween the pulses was set to 60 μs. 2H NMR spectra were dePaked and
smoothed order parameter proﬁles were determined: for details, see
[18]. All NMR experiments were performed at 30 °C. The concentration
of sterols in themembranes was veriﬁed bymeasuring 1H NMR spectra
of the vesicles redissolved in deuterated chloroform and relating the
integrated peaks of the methyl group of the sterol to those of the phos-
pholipid head group.
2.6. Labeling of cells with ﬂuorescent sterols
Chinese Hamster Ovary (CHO-K1) cells were grown in 35-mm-
diameter microscopy dishes in Dulbecco's modiﬁed Eagle medium
(DMEM, PAA Laboratories GmbH, Austria) containing 10% fetal bo-
vine serum. For labeling the cells, 4 nmol of the respective sterol
was given from a stock solution in chloroform into a glass tube and
the solvent was evaporated under a stream of nitrogen. Sterols were
solubilized by the addition of 1 ml DMEM additionally containing
1.5 mM MβCD. Cells were washed twice with DMEM and incubated
with the label solution for 1 min at 37 °C. After three washings with
DMEM, cells were subjected to ﬂuorescence microscopy.
2.7. Fluorescence microscopy
For confocal laser scanning microscopy (CLSM) and ﬂuorescence
lifetime imaging microscopy (FLIM) of the cells, an inverted FluoView
1000 microscope (Olympus, Tokyo, Japan) was used which was mod-
iﬁed for FLIM measurements with a time-resolved LSM Upgrade kit
(PicoQuant, Berlin, Germany). Fluorescence intensity and FLIM im-
ages were obtained with a 60× water objective (numerical aperture
1.2) with a frame size of 512 × 512 pixels at 25 °C. For confocal imag-
ing, NBD and BODIPY were excited using an argon laser diode and
observed in a detection range between 500 and 600 nm. For lifetime
measurements, both ﬂuorophores were excited using a pulsed 485 nm
laser diode with a 10 MHz pulse frequency and detected using a τ single
photon avalanche photodiode (τ-SPAD, PicoQuant, Berlin, Germany)equipped with a 540/40 bandpass ﬁlter. SPAD signals were processed
with the TimeHarp 300 photon counting board and analyzed with the
SymPhoTime software (PicoQuant, Berlin, Germany) taking into ac-
count the instrument response function to allow consideration of
short lifetime components with a high accuracy. FLIM images were ac-
quired as described previously [19]. Brieﬂy, images were accumulated
for 98 s with an average photon count rate of 40,000–60,000 counts
per second.
For ﬂuorescence anisotropy imaging microscopy (FAIM), the setup
for FLIM imaging was used which was expanded by a setup for ﬂuores-
cence anisotropy imaging (PicoQuant, Berlin, Germany). The polarized
emitted lightwas separatedwith a polarization beam splitter and paral-
lel and perpendicularﬂuorescence signalswere detected using a 540/30
and a 540/40 emission ﬁlter, respectively, prior to a τ-SPAD and Perkin/
Elmer SPAD. The g-factor was calculated from point scans of the emis-
sion signals on both channels using an Alexa488 solution. Since the
rotational correlation time of this dye is signiﬁcantly higher than its
average ﬂuorescence lifetime the g-factor can be approximated by the
quotient of parallel and perpendicular ﬂuorescence intensity. A value
of 1.6 was found for the setup described. Fluorescence anisotropy im-
ages were accumulated for 90 s with an average photon count rate of
50,000–100,000 counts per second. Images were analyzed using the
SymPhoTime software.
3. Results
3.1. Ability of CDs to extract ﬂuorescent cholesterol analogs
LUVs containing the different cholesterol analogs were mixed with
various CDs (ﬁnal concentration, 1 mM) at 37 °C, and the ﬂuorescence
intensity was recorded as a function of time (Fig. 2, upper row). The
highest extent of extraction, i.e. the largest decrease of ﬂuorescence,
was observed with MβCD. For NBDCh, some release was observed
upon the addition of HPβCD,βCD, and γCD. NBDChwasmost efﬁciently
extracted, whereas the extraction of BCh-2 was signiﬁcantly lower. For
BCh-1, we observed no release from the membrane in the presence of
any CD used here.
3.2. MβCD-mediated extraction of ﬂuorescent cholesterol analogs
depends on the CD concentration and on the analog species
Since we observed that the extraction of ﬂuorescent cholesterols was
largest for MβCD and since it is well described that this CD forms a com-
plex with cholesterol, the concentration dependence of MβCD-mediated
analog extraction was investigated in more detail (Fig. 2, lower row). As
already observed for the various CDs, the extractability dependence de-
creased in the sequence NBDCh > BCh-2 > BCh-1. For BCh-1, which is
not released frommembranes up to 1 mMMβCD, a signiﬁcant extraction
was measured at 5 and 10 mM. These differences in sterol extractability
are underlined by the dependence of the extent of extraction on the
MβCD concentration (see Supplementary data, Fig. S1A). The extraction
extent was determined from the plateau values of the individual kinetics
by ﬁtting the kinetics to an exponential equation.
The rate constants of extraction determined from the curve ﬁttings
were similar for the analogs at the different MβCD concentrations
(see Supplementary data, Fig. S1B). The values were in the range of
0.2–0.6 s−1, which corresponds to half times of 1 to 4 s, demonstrating
that the release from the membrane was rapid. Since ﬂuorescent
cholesterols were completely extracted from LUV membranes (at high
MβCD concentrations), the transbilayer movement of these analogs
was also in the same time scale or even faster. This is in linewith several
studies that have shown a very rapid transbilayer mobility of cholesterol
or cholesterol analogs (see [4] and references cited therein). However,
one has to emphasize that the measured kinetics are at the resolution
limit of our experimental setup.
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Fig. 2. CD-mediated release of ﬂuorescent cholesterol analogs from LUVs. LUVs were prepared from DOPC, 0.5 mol% Rh-PE, and 0.5 mol% BCh-1, BCh-2, or NBDCh. The vesicles (lipid
concentration, 35 μM) were mixed with 1 mM (ﬁnal concentration) of the indicated CDs (upper row) or with the indicated concentrations of MβCD (lower row). The decrease of
FRET from BODIPY or NBD to Rh was measured at 37 °C from the decrease of ﬂuorescence intensity at 590 nm (excitation at 470 nm). For the sake of clarity, the designation of the
curves is not given for all cases. In the case of HBS (upper row) or 0 (lower row), only HBS (without CD) was added. The curves were normalized by setting the ﬂuorescence in-
tensities before addition of CD to one and the intensities after addition of Triton X-100 to zero.
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analogs by MβCD
Next, we assessed whether the presence of endogenous cholester-
ol affects the extractability of the ﬂuorescent cholesterol analogs. The
extraction of the analogs from LUVs prepared from DOPC upon the
addition of MβCD was compared in the absence and in the presence
of cholesterol in the LUVs. Fluorescence kinetics (not shown) were
ﬁtted to exponential equations as described above to estimate the ex-
tent and the time constants of extraction. With the exception of some
data points, both parameters revealed that the presence of cholesterol
has no signiﬁcant inﬂuence on the MβCD-mediated extraction of all
three analogs (see Supplementary data, Fig. S2).
3.4. Orientation of cholesterol analogs within the lipid membrane
The orientation of the ﬂuorescent cholesterol analogs with respect
to the membrane normal was determined and compared to that of
natural cholesterol. In native cholesterol, the 3β-hydroxyl group is
oriented toward the aqueous phase and the sterol ring system is di-
rected to the hydrophobic core of the membrane [20–22]. We carried
out 1H MAS NOESY experiments to determine the orientation of
BCh-1. 1H MAS NOESY is a valuable tool for the determination of
the membrane orientation of small molecules [23]. A qualitative anal-
ysis of the intermolecular BODIPY-phospholipidNOESY crosspeaks shows
that the aromatic ring protons of the BODIPY-group interactwith the seg-
ments of the lower end of the alkyl side chain of POPC (predominantly
with the terminal CH3, and the (CH2)n groups, the crosspeak at
~2.3 ppm is due to the intramolecular cross-relaxation with the methyl
groups of the pyrrole of BODIPY) but not with the upper alkyl chain, the
glycerol or the headgroup protons (α, β, and γ) of POPC, which are locat-
ed close to the aqueous phase of themembrane (see Supplementary data,
Fig. S3). This suggests a location of this probe in the lower half of the
membrane.
To validate these results, ﬂuorescence quenching by EPR probes
covalently linked to different positions of phospholipids was studied
(Fig. 3). For BCh-1 low quenching efﬁciency of the BODIPY groupwas foundwith Tempo-, 5-Doxyl-, and 10-Doxyl-PC, butmarkedly higher
quenching was observed with 16-Doxyl-PC. This suggests that BCh-1 is
incorporated into the bilayer in the same orientation as natural cholester-
ol and that the BODIPY-group is inserted deeply into the hydrophobic
membrane core, where the spin probe of 16-Doxyl-PC is located. For
BCh-2, the extent of ﬂuorescence quenching showed a similar result:
the quenching efﬁciency was relatively low for Tempo- and 5-Doxyl-PC,
but about twice as high for 10-Doxyl- and 16-Doxyl-PC. This result sug-
gests that BCh-2 is also incorporated into an upright orientation in
the bilayer, but the dynamic distribution of the molecule is somewhat
broader. Fig. 3 shows that with NBDCh the quenching efﬁciency is similar
for Tempo-PC and 5-Doxyl-PC and higher for 16-Doxyl- and, more signif-
icantly, for 10-Doxyl-PC, which argues for an upright orientation in the
bilayer connected with a more shallow average location of this analog
parallel to the membrane normal. This is in agreement with the high
longitudinal dynamics of cholesterol and cholesterol analogs detected
in numerous studies [8]. Previous work based on dithionite quenching
of theNBDgroup indicated thatNBDCh resides in anup-side-downorien-
tation in the membrane [8].
3.5. Lipid condensation effect of cholesterol analogs within the lipid
membrane
In order to investigate the inﬂuence of the cholesterol analogs on
the lipid condensation of membranes, 2H NMR experiments were
performed. From the quadrupolar splitting of 2H NMR spectra, the
smoothed order parameter proﬁle of a deuterated lipid chain can be
calculated (Fig. 4). The addition of 20 mol% cholesterol increased the
order parameters of the lipid acyl chains compared to the sterol-free
membrane. Therefore, in the presence of cholesterol, the area per lipid
decreases and the packing density of the phospholipids increases. This
effect is a consequence of van der Waals interactions between choles-
terol and phospholipids [24]. As order parameters directly display the
lipid chain order and thus the degree of lipid condensation, they allow
assessment of the suitability of an analog to mimic natural cholesterol.
Nearly no increase in the order parameterwas observed in the presence
of 20 mol% of each of the three cholesterol analogs (Fig. 4).
Fig. 3. Fluorescence quenching efﬁciency of the BODIPY group of BCh-1, and BCh-2, and
of the NBD group of NBDCh by Tempo-PC, 5-Doxyl-PC, 10-Doxyl-PC, and 16-Doxyl-PC
in POPC LUVs at 25 °C.
Fig. 4. Smoothed order parameter proﬁle of pure POPC-d31 MLVs (x) and of POPC-d31
MLVs in the presence of 20 mol% cholesterol (+), BCh-1 (●), BCh-2 (▲), and NBDCh
(■).
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Besides extracting ﬂuorescent sterols from membranes in the pres-
ence of MβCD, sterol/CD complexes can be used also to incorporate
these molecules into membranes. Incubating CHO-K1 cells with a solu-
tion containingMβCDandNBDCh, BCh-1 or BCh-2 resulted in an effective
labeling of the cells with the ﬂuorophores allowing the application of
different approaches of ﬂuorescencemicroscopy, like confocal laser scan-
ning (CLSM), lifetime imaging (FLIM) and anisotropy imaging (FAIM)
microscopy (Fig. 5). Incubating the cells with the analogs in the absence
of MβCD, ﬂuorescence labeling was very low (data not shown).
4. Discussion
Fluorescent analogs of cholesterol have been widely used in the
last years in membrane biophysical and cell biological studies. The in-
teraction between CDs and labeled cholesterols has not been investi-
gated in detail until now. In the present study, we investigated the
ability of various CDs to extract three ﬂuorescent cholesterol analogs
from lipid membranes by using a newly developed assay to record thechange of FRET between a rhodamine moiety linked to PE and the NBD
or BODIPY moiety linked to cholesterol upon the addition of CDs. Three
ﬂuorescent cholesterols were employed: NBD- (NBDCh) and two
BODIPY-linked cholesterol analogs (BCh-1 and BCh-2), each bearing
the ﬂuorescence moiety at the end of the sterol's aliphatic side chain
(for structures, see Fig. 1). Whereas one of these analogs (BCh-1) has
been shown to be a suitable replacement for endogenous cholesterol
[13,25–27], the other two (BCh-2 and NBDCh) do not reﬂect the prop-
erties of cholesterol (see Introduction). Our data with different CDs at
the same concentration and with MβCD at different concentrations
show that the analogs are differently extracted from LUVs. In order to
explain the different extractabilities of cholesterol analogs on amolecu-
lar level, the lipid condensation effect of cholesterol analogs and their
orientation within the lipid membrane were investigated.
With regard to the latter point, it was found that the general ori-
entation of the cholesterol analogs appears to be similar to that of
native cholesterol, at least for the two BODIPY analogs. It is surprising
that the zwitterionic BODIPY-group is located in the hydrophobic part
of the membrane as the ﬁxed charges should give rise to signiﬁcant
Born repulsion. Nevertheless, subtle differences in the molecular dy-
namics of the two BODIPY-cholesterol molecules have been observed,
which are also a consequence of the high molecular dynamics of all
molecules that constitute lipid model membranes [8,28,29]. The aver-
age location of the ﬂuorophore of the NBDCh appears to be somewhat
more shallow. Previous work has focused on the inverse orientation
of NBDCh inferred from the rapid reduction by dithionite ion [8].
The NBD group has a preference for a localization in the lipid water inter-
face as found for NBD labeled phospholipids ([30,31], see above). Appar-
ently, the altered distribution of NBDCh determines the extractability of
the molecule with regard to the various CDs.
Regardless of the orientation and the extractability by CDs, all cho-
lesterol analogs at 20 mol% show insufﬁcient lipid condensation com-
pared with that observed with native cholesterol. In all three cases
the large bulky charged ﬂuorescent groups prevent the phospholipid
fatty acyl chains from signiﬁcant ordering, possibly because of self
aggregation of the ﬂuorescent analogs. However, as discussed before
[8], in ﬂuorescence studies only a very low mol% of the ﬂuorescent
analog is used. Thus, even though the cholesterol analog may not fully
reﬂect the properties of native cholesterol, it senses the right environ-
ment. For instance, BCh-1 was shown to be the only ﬂuorescent analog
that partitions into the lo phase of phase separated giant unilamellar
vesicles [27].
Our data provoke two questions for understanding the molecular
mechanism(s) of sterol extraction from membranes. The ﬁrst ques-
tion relates to the extractability of native cholesterol compared to
that of its ﬂuorescent analogs. The results of the present study, i.e.
Fig. 5. Fluorescence microscopy of CHO-K1 cells labeled with ﬂuorescent cholesterols. Cells were labeled with NBDCh, BCh-1 or BCh-2 in the presence of MβCD as described in
Materials and methods and observed by confocal laser scanning microscopy (CLSM), ﬂuorescence lifetime imaging microscopy (FLIM) and ﬂuorescence anisotropy imaging micros-
copy (FAIM). The average lifetimes and the anisotropies are shown as pseudocolor (see the scales on the bottom).
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the ﬂuorescent cholesterols, indicate that the native molecule is released
more slowly. This notion is supported by a study of Ohvo-Rekilä et al. [32],
who measured the desorption of cholesterol and the ﬂuorescent sterols
DHE and cholestatrienol from monolayers in the presence of HPβCD.
They found a 13-fold faster release of the analogs compared to
cholesterol. The second question relates to the parameters, which inﬂu-
ence the extractability of sterols. Our data, i.e. a different extraction of
ﬂuorescent cholesterols vs. their common incapability to induce a lipid
ordering, suggest that the impact of sterols on phospholipid order is
only one parameter inﬂuencing the extraction process. This assumption
is also supported by the data of Ohvo-Rekilä et al. [32], who found a dif-
ferent release of cholestatrienol and cholesterol from lipid monolayers.
However, it has been shown that cholestatrienol causes a similar lipid
condensation as cholesterol [8]. Therefore, it can be surmised that a
number of parameters determine the extraction of labeled and native
cholesterol from membranes, which are the impact of sterols on lipid
order, the hydrophobicity of the sterols, the intermolecular interactions
(sterol–sterol; sterol–phospholipid), the orientation of the sterols within
the membrane, and the afﬁnity of the sterols to the acceptor [32].However, the molecular details of the release of sterols to exogenous
acceptors are still largely unknown [7,33,34].
βCDs can also be used to incorporate the ﬂuorescent sterols into
preformedmembranes e.g. into plasmamembranes, allowing the appli-
cation of various approaches of ﬂuorescence microscopy. This has been
used to characterize various processes of the cellular cholesterol trafﬁc
[6,25,26,35,36]. However, it has to be ensured that the cholesterol con-
tent of membranes is not affected during the labeling procedure since
endogenous cholesterol could be extracted by the CD.Moreover, partic-
ular attention has to be paid not to label the membranes with too large
concentration of the ﬂuorescent cholesterol since themolecular process
under investigation might not be correctly reﬂected by the analog.
In summary, our data are relevant for experiments using these ﬂuo-
rescent cholesterol analogs in biological studies. The cholesterol analogs
can provide useful information, but the data have to be interpreted cau-
tiously with respect to the powers and weaknesses of the respective
analogs. Therefore, the search forﬂuorescent analogs that reﬂect all prop-
erties of natural cholesterol remains an important challenge. Our results
are also important for an understanding of the molecular processes of
cholesterol release to physiological, extracellular acceptors of cholesterol.
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